ZHOK $72.30 0%
PRIO3.SA $34.49 -0.9477%
PPTY $27.40 -1.0284%
BAS.BR $15.00 0%
SEB $3 783.20 -1.0346%
1059.HK $0.34 0%
0QZF.L $32.85 1.1082%
JPMB $38.87 -0.4079%
IBND $28.46 -0.6285%
IUIT.L $19.03 -0.3144%
SDIA.L $5.49 -0.1728%
K71U.SI $0.87 -0.5747%
DNM.L $80.00 -1.8405%
N91.L $172.50 -0.748%
C2U.PA $6.38 -0.3127%
AIGL.L $2.32 1.5082%
LDEU.L $10.43 0.1825%
LIND $10.01 -6.3611%
0570.HK $4.12 -2.1378%
DDMXU $10.10 0%
MDYV $62.97 -0.7409%
UC04.L $7 701.50 -6.06208%
8096.HK $0.26 -3.7736%
CIFR $1.97 -1.99%
ITQ $10.17 0%
PECO $29.35 -0.4072%
CHSR.PA $5.15 0%
LEGH $22.50 -1.0989%
FRAF $24.90 -0.1604%
7300.HK $5.35 0.7533%
HUN $25.03 0%
RTO.L $645.60 0.3419%
0KGH.L $264.50 -0.0679%
PCG $17.41 0.3458%
0L8B.L $69.45 -1.2513%
IBB $129.53 -0.69%
0KUR.L $31.10 1.3987%
CRSAW $1.60 0%
KRT $15.73 2.6436%
SMDD $21.84 1.7092%
SCPL $16.71 -4.7863%
ELOX $3.71 -9.0686%
HNGR $18.72 0%
ALBKK.PA $17.80 -1.385%
VNT $27.72 -0.8762%
AAN $12.38 -1.4729%
FDLO $48.57 -0.2772%
AGM-PC $25.70 -0.9248%
2660.HK $2.87 -1.0345%
DYNS $7.51 0%
GLOB $136.76 -1.1635%
BIBL $30.40 -0.0983%
QTEK $0.18 -4.2201%
CGBD $13.38 -0.5204%
1446.HK $0.30 1.6949%
LMRKN $25.50 0%
SLAM $10.45 0.0958%
1481.HK $0.27 1.9231%
IDAR.L $22.51 -0.3322%
CASS $37.48 -1.0103%
PEAK $20.85 -1.0911%
LCI $0.69 0%
2208.HK $6.09 -2.7157%
NHICW $0.01 0%
WINC $23.69 -0.0207%
0R18.L $70.97 -0.8176%
2333.HK $9.80 -3.1621%
KORU $7.75 -4.0842%
0RHV.L $99.86 0.8734%
IXJ $85.82 -0.3715%
ALHUN.PA $12.80 -0.7752%
IGIC $8.30 -0.5988%
FLY $17.03 0%
VCIF $9.63 -0.9259%
2599.HK $0.18 0%
VINO.L $34.50 1.4706%
CSL $207.25 -0.1902%
FTSV.L $4.25 750%
VONG $63.51 -0.8276%
WINVR $0.07 16.899%
OXLC $5.19 -0.3647%
EKG $17.29 -0.1155%
1676.HK $1.85 4.5198%
ZIG $27.19 -0.2762%
GMTA $25.03 0%
CRPR.L $750.00 2.0408%
MJ $3.21 -2.1951%
1705.HK $0.30 0%
0111.HK $0.33 -2.9412%
BHB $22.41 -0.8189%
XCO2.L $15.17 -0.0659%
PRTA $72.08 -1.9053%
LSCC $80.90 -0.0679%
CIVB $14.78 -2.9547%
PAQCW $0.36 0%
ALEMV.PA $1.29 -0.7692%
CMIN3.SA $4.41 0.9153%
FJP $46.06 -0.3677%
TPX $38.12 2.0616%
1736.HK $0.03 -6.25%
Eng
Логотип
Eng
Лого

Faron Pharmaceuticals Oy FARN.L

$298.00

-$5.88 (-1.97%)
На 18:02, 12 мая 2023

Ранг: 3

Ранг - это оценка кредитоспособности корпорации.

Ключевые показатели

  • Marketcap

    198747801.00000000

  • week52high

    395.00

  • week52low

    2.10

  • Revenue

    0

  • P/E TTM

    -596

  • Beta

    0.17900700

  • EPS

    -0.45000000

  • Last Dividend

    0.00000000

  • Next Earnings Date

    02 мар 2023 г. в 12:00

Описание компании

Faron Pharmaceuticals Oy operates as a clinical stage drug discovery and development company. The company develops a pipeline of immune modulation based proprietary drug candidates for unmet need, including immuno-oncology, and organ protection and regenerative medicine. Its lead product candidates are Traumakine, an intravenous interferon beta-1a therapy for the treatment of acute respiratory distress syndrome, COVID-19, acute kidney injury, cardiac protection, solid organ transplant, and ischemia reperfusion injury; and Bexmarilimab, a novel precision cancer immunotherapy candidate for treating solid tumors, non-small cell lung carcinoma, and hematological malignancies. The company also develops Haematokine, a new chemical entity AOC3 inhibitor for the treatment of hematological malignancies and bone marrow. Faron Pharmaceuticals Oy was founded in 2003 and is headquartered in Turku, Finland.

Свежие комментарии

Оставьте свой голос

Анонимное голосование

Будет ли рост российского рынка к концу года?

  • Да

    87%

  • Нет

    12%

Проголосовал 8 человек